Table 1.
A. All-trans retinoic acid entries in the PDB
| ||||
---|---|---|---|---|
PDB ID | Resolution (Å) | Protein Description | R/Rfree | SF |
1CBR | 2.90 | Holo cellular RA-binding protein type I | 0.251/0.320 | |
1CBS | 1.80 | Holo cellular RA-binding protein type II | 0.200/0.237 | |
1EPB | 2.20 | Epididymal RA-binding protein | 0.182 | N/A |
1FEM | 1.90 | Bovine plasma retinol-binding protein | 0.184 | N/A |
1GX9 | 2.34 | Bovine β-lactoglobulin | 0.226/0.298 | N/A |
1N4H | 2.10 | Orphan nuclear receptor ROR-β | 0.217/0.255 | N/A |
1RLB | 3.10 | Transthyretin and retinol-binding protein | 0.215 | N/A |
2FR3 | 1.48 | Apo-wild-type cellular RA-binding protein type II | 0.131/0.174 | N/A |
2G78 | 1.70 | The R132K:Y134F mutant of cellular RA-Binding protein type II | 0.151/0.203 | N/A |
2LBD | 2.06 | Ligand-binding domain of the human RAR-γ | 0.210/0.313 | |
2VE3 | 2.10 | Cyanobacterial cytochrome P450 CYP120A1 | 0.225/0.267 | |
3CWK | 1.60 | Cellular RA-binding protein type II-R132K:Y134F:R111L:L121E:T54V | 0.125/0.167 |
B. 9-cis retinoic acid entries in the PDB
| ||||
---|---|---|---|---|
PDB ID | Resolution (Å) | Protein Description | R/Rfree | SF |
1FBY | 2.25 | Human RXR-α ligand binding domain | 0.228/0.263 | N/A |
1FM6 | 2.10 | Human RXR-α and PPAR-γ ligand binding domain | 0.250/0.292 | |
1FM9 | 2.10 | Human RXR-α and PPAR-γ ligand binding domain | 0.239/0.268 | |
1G5Y | 2.00 | RXR-α ligand binding domain | 0.231/0.254 | N/A |
1K74 | 2.30 | Human RXR-α and PPAR-γ ligand binding domain | 0.238/0.279 | N/A |
1TYR | 1.80 | Transthyretin | 0.196 | N/A |
1XDK | 2.90 | RAR-β/RXR-α ligand binding domain | 0.253/0.296 | |
2ACL | 2.80 | Liver X receptor agonists | 0.220/0.280 | |
2NNH | 2.60 | Cytochrome P450 | 0.172/0.267 | |
3LBD | 2.40 | Human nuclear receptor RAR-γ | 0.210/0.313 | N/A |
3DZU | 3.20 | PAR-γ-RXR-α nuclear receptor complex on DNA | 0.201/0.272 | |
3DZY | 3.10 | PAR-γ-RXR-α nuclear receptor complex on DNA | 0.213/0.268 |